National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries

Abstract Background Although high-density lipoprotein (HDL) and non-HDL cholesterol have opposite associations with coronary heart disease, multi-country reports of lipid trends only use total cholesterol (TC). Our aim was to compare trends in total, HDL and non-HDL cholesterol and the total-to-HDL cholesterol ratio in Asian and Western countries. Methods We pooled 458 population-based studies with 82.1 million participants in 23 Asian and Western countries. We estimated changes in mean total, HDL and non-HDL cholesterol and mean total-to-HDL cholesterol ratio by country, sex and age group. Results Since ∼1980, mean TC increased in Asian countries. In Japan and South Korea, the TC rise was due to rising HDL cholesterol, which increased by up to 0.17 mmol/L per decade in Japanese women; in China, it was due to rising non-HDL cholesterol. TC declined in Western countries, except in Polish men. The decline was largest in Finland and Norway, at ∼0.4 mmol/L per decade. The decline in TC in most Western countries was the net effect of an increase in HDL cholesterol and a decline in non-HDL cholesterol, with the HDL cholesterol increase largest in New Zealand and Switzerland. Mean total-to-HDL cholesterol ratio declined in Japan, South Korea and most Western countries, by as much as ∼0.7 per decade in Swiss men (equivalent to ∼26% decline in coronary heart disease risk per decade). The ratio increased in China. Conclusions HDL cholesterol has risen and the total-to-HDL cholesterol ratio has declined in many Western countries, Japan and South Korea, with only a weak correlation with changes in TC or non-HDL cholesterol.

Gretchen A. Stevens | M. Jarvelin | T. Lehtimäki | V. Salomaa | A. Dobson | Qian Wang | V. Gudnason | I. Pigeot | W. Ahrens | U. Ekelund | M. Ezzati | I. Janszky | C. Schmidt | M. Vrijheid | P. Metcalf | Y. Khang | M. Sjöström | F. Gutzwiller | F. Rodríguez‐Artalejo | D. Gu | P. Whincup | C. Meisinger | A. Evans | D. Arveiler | J. Ruidavets | J. Saramies | J. Tuomilehto | A. Döring | J. Staessen | L. Thijs | Maciej Banach | C. Cooper | T. Gill | G. Grosso | J. Jonas | J. Jozwiak | G. Mensah | R. Shiri | R. Topor-Madry | B. Schöttker | G. Danaei | J. Salonen | P. Amouyel | G. De Backer | M. Müller-Nurasyid | J. Eriksson | S. Kiechl | P. Willeit | J. Willeit | S. Keinänen-Kiukaanniemi | T. Laatikainen | A. Yoshihara | G. Stevens | M. Ferrari | R. Beaglehole | C. Tzourio | F. Panza | A. Petersmann | S. Wannamethee | E. Mathiesen | D. De Bacquer | U. Keil | B. Boehm | S. Anderssen | T. Wilsgaard | P. Vollenweider | T. Aspelund | W. Kratzer | Jiang He | I. Huybrechts | U. Kujala | G. Ning | Y. Bi | K. Ronkainen | A. Wong | J. Ferrières | T. Ninomiya | L. Baur | C. Björkelund | A. Rosengren | J. Bentham | E. Manzato | M. Salvetti | Weili Yan | Bin Zhou | Honor Bixby | Melanie J. Cowan | J. Bennett | K. Hajifathalian | L. Riley | W. Aekplakorn | A. Amuzu | I. Ariansen | M. Avdičová | P. Bandosz | J. Banegas | C. Barbagallo | I. Bata | Simona Bo | V. Bongard | Juergen Breckenkamp | V. Capuano | F. Casanueva | J. Casas | C. Caserta | Fangfang Chen | Shuohua Chen | B. Cho | Yumi Cho | J. Chudek | R. Cífková | F. Claessens | E. Clays | S. Costanzo | D. Cottel | C. Cowell | A. Crujeiras | G. D’Arrigo | J. Dallongeville | L. Dauchet | V. Deschamps | C. Donfrancesco | W. Drygas | R. Eggertsen | D. Faeh | F. Félix-Redondo | D. Fernández-Bergés | J. Finn | Ann-Sofie Forslund | M. Forsner | G. Frontera | Y. Fujita | Z. Gaciong | S. Garnett | J. Gaspoz | Magda Gasull | Louise Gates | S. Giampaoli | F. Gianfagna | J. Giovannelli | F. Gottrand | S. Graff-Iversen | R. D. Gregor | T. Grodzicki | G. Gruden | I. Guessous | Johanna Gunnlaugsdottir | J. Hata | S. Herrala | L. Iacoviello | A. Iannone | Nayu Ikeda | M. Iwasaki | K. Jamrozik | G. Jasienska | M. Joffres | M. Kersting | Jeongseon Kim | J. Klumbienė | E. Kolle | K. Kouda | S. Krokstad | P. Kurjata | K. Kuulasmaa | V. Lánská | G. Lappas | Yanping Li | C. Lilly | L. Lissner | Jing Liu | R. Lorbeer | D. Lukšienė | A. Lundqvist | G. Ma | S. Machi | S. Maggi | D. Magliano | J. Mann | S. McLachlan | R. McLean | A. Meirhaeghe | J. Mi | Jody C Miller | L. Moreno | M. Mossakowska | M. Muiesan | J. Mursu | Harunobu Nakamura | Jana Námešná | W. Neal | Ilona Nenko | M. Noale | D. Noto | D. O’Reilly | Kyungwon Oh | A. Pająk | L. Palmieri | W. Parnell | Markku Peltonen | J. Petkevičienė | L. Pilotto | A. Piwońska | P. Plans-Rubió | J. Price | R. Radišauskas | R. Ramos | J. Redón | F. Rigo | M. Rodríguez-Pérez | D. Romaguera | M. Rutkowski | B. Salanave | S. Sans | K. Saum | A. Schienkiewitz | A. Sen | J. Simons | L. Simons | J. Słowikowska-Hilczer | Przemysław Ślusarczyk | V. Solfrizzi | E. Sonestedt | A. Soumaré | M. Stathopoulou | Bill Stavreski | J. Steene-Johannessen | P. Stehle | J. Stieber | J. Stokwiszewski | P. Suriyawongpaisal | H. Tolonen | M. Torrent | T. Tuomainen | Hannu Uusitalo | D. Vanderschueren | D. Vanuzzo | T. Vega | G. Veronesi | J. Vioque | J. Virtanen | S. Visvikis-Siest | S. Voutilainen | A. Wagner | Ming-dong Wang | A. Więcek | B. Wojtyniak | Haiquan Xu | X. Ye | S. Zambon | T. Zdrojewski | Wenhua Zhao | S. Schipf | M. Nauck | Janine Clarke | E. Kajantie | J. Sundström | S. Sebert | S. Tsugane | C. Taddei | Jeonghee Lee | P. Lytsy | Frederick C W Wu | Liang Xu | Xiaoguang Yang | G. de Gaetano | R. Korpelainen | S. De Henauw | F. Galvano | J. Jokelainen | G. Tell | S. Kriemler | E. Dennison | D. De Smedt | A. Cabrera de León | J. Puder | D. Stöckl | M. Knoflach | T. Niiranen | D. Goltzman | Dong Zhao | Yong Du | C. Scheidt-Nave | W. Hopman | P. Guallar-Castillón | E. Dziankowska-Zaborszczyk | Shouling Wu | D. Salmerón | M. Bonaccio | M. Chirlaque | M. García-de-la-Hera | E. Gudmundsson | Garry Jennings | Seung-lyeal Jeong | J. Kauhanen | Yeon-Yong Kim | Scott B. McLean | Sawada Norie | Ö. Ólafsson | Joel G. R. Roy | K. Van Herck | M. Di Cesare | S. Savin | E. López-García | J. Auvinen | S. Morin | Anne M. Wagner | Anthony Joseph Hayes | Jennifer Servais | A. Bienek | P. Marques-Vidal | L. Censi | Jingli Gao | M. Busch | R. Lundqvist | Soile Puhakka | Yu-na He | H. Borghs | L. Cui | T. Haugsgjerd | Wenbin Wei | M. Porta | R. Jackson | R. Borchini | Annette Peters | Lars Lind | J. Shaw | H. Brenner | L. E. Laugsand | U. Kiechl-Kohlendorfer | G. Bernotiene | M. Woodward | O. Raitakari | R. Adams | Kenjiro Shibuya | José MaríaHuerta | Xu Lin | Graziella Bruno | Dušan Grafnetter | M. Hobbs | Anne Taylor | L. Vatten | R. Elosúa | L. Lind | S. Koskinen | S. Söderberg | M. Cowan | S. Ko | D. Debacquer | A. Tamošiūnas | A. DiCastelnuovo | Marcela GonzalezGross | R. Hardy | Ilpo TapaniHihtaniemi | Chao QiangJiang | Tai HingLam | José EugenioLozano | Eva MariaNavarrete-Muñoz | Terence O'Neill | Fred MichelPaccaud | Dong WookShin | Eng JooTan | M. JoséTormo | Ya XingWang | Aleksander GiwercmanWu | H. Bixby | S. Puhakka | Garry L R Jennings | Per Lytsy | A. Evans | Kaveh Hajifathalian | J. Eriksson | S. de Henauw | Olli T. Raitakari | Kimmo Ronkainen | S. Wannamethee | Ann‐Sofie Forslund

[1]  L. Zhiping,et al.  Children’s Hospital of Fudan University , 2019, Healthcare Quality and HIT - International Standards, China Practices.

[2]  Gretchen A. Stevens,et al.  Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.

[3]  N. M. Nasir,et al.  Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study. , 2017, The lancet. Diabetes & endocrinology.

[4]  Michael Miller,et al.  Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association , 2017, Circulation.

[5]  Hynek Pikhart,et al.  Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants , 2017, The Lancet.

[6]  Gretchen A. Stevens,et al.  A century of trends in adult human height , 2016, eLife.

[7]  P. Elliott,et al.  Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects: Current Knowledge and Data Gaps , 2016, Circulation.

[8]  W. Parnell,et al.  Trends in serum total cholesterol and dietary fat intakes in New Zealand between 1989 and 2009 , 2016, Australian and New Zealand journal of public health.

[9]  V. Salomaa,et al.  40-Year CHD Mortality Trends and the Role of Risk Factors in Mortality Decline: The North Karelia Project Experience. , 2016, Global heart.

[10]  F. Kronenberg,et al.  Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med , 2016, Clinical chemistry.

[11]  Gretchen A. Stevens,et al.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants , 2016, Lancet.

[12]  Dajiang J. Liu,et al.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease , 2016, Science.

[13]  Gert B. M. Mensink,et al.  Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11 , 2016, BMC Public Health.

[14]  L. Kuller,et al.  Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study. , 2015, International journal of epidemiology.

[15]  Luigi Palmieri,et al.  Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 1998–2012 , 2015, European journal of preventive cardiology.

[16]  D. Jacobs,et al.  High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis , 2015, Journal of the American Heart Association.

[17]  Barry J. Davis,et al.  Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials , 2015, The Lancet.

[18]  D. Rader,et al.  HDL and cardiovascular disease , 2014, The Lancet.

[19]  P. Ridker LDL cholesterol: controversies and future therapeutic directions , 2014, The Lancet.

[20]  M. Bobák,et al.  Trends in Prevalence of Dyslipidaemias and the Risk of Mortality in Lithuanian Urban Population Aged 45–64 in Relation to the Presence of the Dyslipidaemias and the Other Cardiovascular Risk Factors , 2014, PloS one.

[21]  A. Eggen,et al.  Trends in cardiovascular risk factors across levels of education in a general population: is the educational gap increasing? The Tromsø study 1994–2008 , 2014, Journal of Epidemiology & Community Health.

[22]  H. Ueshima,et al.  High-density lipoprotein levels have markedly increased over the past twenty years in Japan. , 2014, Journal of atherosclerosis and thrombosis.

[23]  B. Popkin,et al.  Dynamics of the Chinese diet and the role of urbanicity, 1991–2011 , 2014, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[24]  P. Joshi,et al.  Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. , 2013, Journal of the American College of Cardiology.

[25]  V. Salomaa,et al.  What have we learnt about high-density lipoprotein cholesterol measurements during 32 years? Experiences in Finland 1980-2012. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[26]  M. Carroll,et al.  Trends in lipids and lipoproteins in US adults, 1988-2010. , 2012, JAMA.

[27]  John Spertus,et al.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.

[28]  Jiang He,et al.  Serum Lipids and Lipoproteins in Chinese Men and Women , 2012, Circulation.

[29]  H. Joung,et al.  A traditional Korean dietary pattern and metabolic syndrome abnormalities. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[30]  F. Paccaud,et al.  Trends in food availability in Switzerland, 1961–2007 , 2012, European Journal of Clinical Nutrition.

[31]  William Weintraub,et al.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.

[32]  D. Kim,et al.  Causes of Different Estimates of the Prevalence of Metabolic Syndrome in Korea , 2011, The Korean journal of internal medicine.

[33]  N. Santoro The Study of Women's Health Across the Nation (SWAN) . , 2011, Obstetrics and gynecology clinics of North America.

[34]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[35]  A. Pathak,et al.  Vascular Health and Risk Management Dovepress Eprosartan-based Hypertension Therapy, Systolic Arterial Blood Pressure and Cognitive Function: Analysis of Middle East Data from the Oscar Study , 2022 .

[36]  Gretchen A. Stevens,et al.  National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants , 2011, The Lancet.

[37]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[38]  Gretchen A. Stevens,et al.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants , 2011, The Lancet.

[39]  P. Whincup,et al.  Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[40]  R. Cífková,et al.  Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. , 2010, Atherosclerosis.

[41]  E. Vartiainen,et al.  Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland , 2010, Public Health Nutrition.

[42]  Nicholas J Wareham,et al.  Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. , 2009, Journal of the American College of Cardiology.

[43]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[44]  D. Arveiler,et al.  Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007. , 2009, Archives of cardiovascular diseases.

[45]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[46]  Jennifer G. Robinson,et al.  Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. , 2009, Journal of the American College of Cardiology.

[47]  H. Iso Changes in Coronary Heart Disease Risk Among Japanese , 2008, Circulation.

[48]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[49]  A. Plasència,et al.  Trends in blood lipids and fat soluble vitamins in Catalonia, Spain (1992–2003) , 2007, Public Health Nutrition.

[50]  Yan Li,et al.  [The changing trend of serum total cholesterol in Beijing population aged 25 - 64 years during 1984 - 1999]. , 2006, Zhonghua nei ke za zhi.

[51]  P. Metcalf,et al.  Trends in major cardiovascular risk factors in Auckland, New Zealand: 1982 to 2002-2003. , 2006, The New Zealand medical journal.

[52]  T. Walley,et al.  Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. , 2005, British journal of clinical pharmacology.

[53]  P. Sorlie,et al.  Trends in serum lipids and lipoproteins of adults, 1960-2002. , 2005, JAMA.

[54]  조남욱 전자/제조업의 Collaboration 전략 , 2003 .

[55]  F. Sacks,et al.  Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. , 2002, The American journal of medicine.

[56]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[57]  Healthy Communities Division Public Health Agency of Canada - Canada's Physical Activity Guide for Youth - Physical Activity Statistics , 2002 .

[58]  H. Hense,et al.  Trends in coronary risk factors in the WHO MONICA project. , 2001, International journal of epidemiology.

[59]  G R Warnick,et al.  Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. , 2001, Clinical chemistry.

[60]  P Langenberg,et al.  Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. , 2001, Archives of internal medicine.

[61]  Y. Matsumura,et al.  Nutrition trends in Japan. , 2001, Asia Pacific journal of clinical nutrition.

[62]  E. Ford,et al.  Glycemic index and serum high-density lipoprotein cholesterol concentration among us adults. , 2001, Archives of internal medicine.

[63]  A. Dobson,et al.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations , 2000, The Lancet.

[64]  F. Gutzwiller,et al.  Trends in cardiovascular risk factors (1984-1993) in a Swiss region: results of three population surveys. , 1997, Preventive medicine.

[65]  T. Manolio,et al.  Changes over time in blood lipids and their correlates in Polish rural and urban populations: the Poland-United States Collaborative Study in cardiopulmonary disease epidemiology. , 1997, Annals of epidemiology.

[66]  P. Magnus,et al.  Trends in cardiovascular risk factors in Australia: Results from the National Heart Foundation's Risk Factor Prevalence Study, 1980‐1989 , 1994, The Medical journal of Australia.

[67]  Gunnar Sigurdsson,et al.  Decline in ischaemic heart disease in Iceland and change in risk factor levels. , 1991, BMJ.

[68]  O. Jeanneret,et al.  [Institute for Social and Preventive Medicine of the Geneva University: research structures and directions]. , 1979, Sozial- und Praventivmedizin.

[69]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[70]  P. Mãlek [Development of integration process in the Institute for Clinical and Experimental Medicine]. , 1973, Casopis lekaru ceskych.

[71]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[72]  J. Hewitt,et al.  The role of lipids and lipoproteins in atherosclerosis. , 1950, Science.

[73]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[74]  Ian J. Brown,et al.  Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. , 2014, The lancet. Diabetes & endocrinology.

[75]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. , 2012, Lancet.

[76]  W. Howard Trends in Serum Lipids and Lipoproteins of Adults, 1960–2002Carroll MD, Lacher DA, Sorlie PD, et al (Centers for Disease Control and Prevention, Hyattsville, Md; NIH, Bethesda, Md; Univ of Texas, Dallas) JAMA 294:1773–1781, 2005§ , 2006 .

[77]  C. Badiu Harrison's Principles of Internal Medicine 16th ed , 2005 .

[78]  A. Hoes,et al.  [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.

[79]  I. Goldberg,et al.  Disorders of Lipoprotein Metabolism , 2002 .

[80]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[81]  B. Popkin,et al.  The nutrition transition in South Korea. , 2000, The American journal of clinical nutrition.

[82]  N. Yoshiike,et al.  National Nutrition Survey in Japan. , 1996, Journal of epidemiology.